JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Pier Luigi Filosso
Guglielmo Maria Actis Dato
Enrico Ruffini
Maurizio Mancuso
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Filosso, P. L.
Right arrow Articles by Mancuso, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Filosso, P. L.
Right arrow Articles by Mancuso, M.
Related Collections
Right arrow Mediastinum

J Thorac Cardiovasc Surg 2004;127:1215-1219
© 2004 The American Association for Thoracic Surgery


Brief communication

Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): Report of a successful case and review of the literature

Pier Luigi Filosso, MDa,*, Guglielmo Maria Actis Dato, MDb, Enrico Ruffini, MDa, Sergio Bretti, MDc, Franca Ozzello, MDd, Maurizio Mancuso, MDa

a Department of Thoracic Surgery, University of Torino Italy San Giovanni Battista Hospital, Torino, Italy
b Department of Cardiac Surgery, University of Torino Italy San Giovanni Battista Hospital, Torino, Italy
c Service of Medical Oncology, Civil Hospital, Ivrea, Torino, Italy
d Service of Radiation Therapy, Civil Hospital, Ivrea, Torino, Italy

Received for publication August 22, 2003; revisions received September 30, 2003; accepted for publication December 4, 2003.

* Address for reprints: Pier Luigi Filosso, MD, University of Torino Italy, Department of Thoracic Surgery, San Giovanni Battista Hospital, Via Genova, 3, 10126 Torino, Italy
pierluigifillosso@tiscalinet.it

The first 300 words of the full text of this article appear below.

Thymic carcinoid (TC) is a rare entity: since the first description by Rosai and Higa1 in 1972, approximately 150 cases have been reported in the literature. These tumors are frequently associated with endocrinopathies (Cushing syndrome or multiple endocrine neoplasia type 1; MEN-1) and carry a poor prognosis.2,3 TCs present an aggressive biological behavior with a tendency to invade adjacent structures (mediastinal fatty tissue, lung, pericardium, and great vessels) and with a tendency for local recurrences or distant hematogenous metastases.

Surgery, when feasible, represents the treatment of choice3-5 even if, in some cases, radical resection is not achieved. The role of neoadjuvant or adjuvant therapy has not yet been assessed. We describe the successful multidisciplinary management of a giant TC treated with neoadjuvant radiotherapy/chemotherapy, radical surgical resection, and preoperative, intraoperative, and postoperative therapy with a somatostatin analog. In addition, we provide a review of the recent literature about the management of these tumors.

Clinical summary

A 39-year-old man underwent a bioptic left anterior mediastinotomy for a large mediastinal mass, discovered after he presented with cough and dyspnea. Histology revealed grade 2 neuroendocrine carcinoma (atypical carcinoid) of the thymus. Neoplastic tissue strongly expressed somatostatin receptors (sst2), and chromogranin immunostaining was positive. Total body computed tomographic (CT) scan showed involvement of the anterior mediastinum, of the thoracic inlet, and of the left lung (Figure 1). No distant metastases were seen. Indium 111 diethylenetriamine pentaacetic acid pentetreotide scintigraphy (Octreoscan; Mallincrodt Medical BV, Zaltbommel, The Netherlands) confirmed an elective uptake only in correspondence of the tumor (Figure 2).


Figure Removed (Available Only in the Full Text)
View larger version (153K):
[in this window]
[in a new window]
 
Figure 1. CT scan of a giant invasive thymic carcinoid.

 

Figure Removed (Available Only in the Full Text)
View larger version (139K):
[in this window]
[in a new window]
 
Figure 2. Octreoscan shows an elective uptake only in correspondence with the thoracic lesion: no other pathologic images are evident.

 
Serum chromogranin A and neural specific enolase (NSE) levels were 143.3 ng/mL (reference range, 20-100 ng/mL) and 83 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
JCOHome page
M. P. McEvoy, B. S. Rich, M. New, L. H. Tang, and M. P. La Quaglia
Thymic Carcinoid Presenting With Cushing's Syndrome in a 17-Year-Old Boy: A Case Report and Review of the Literature
J. Clin. Oncol., September 1, 2011; 29(25): e716 - e718.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Whitaker
Thymic neuroendocrine carcinoma (carcinoid): What if octreotide scanning is negative?
J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 801 - 801.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. L. Filosso
Reply
J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 801 - 801.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.